Oculis Holding AG Warrants (NASDAQ : OCSAW ) Stock

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Description

Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Quote

Last:	$17.825
Change Percent:	15.37%
Open:	$15.81
Close:	$15.45
High:	$17.825
Low:	$15.79
Volume:	1,500
Last Trade Date Time:	04/14/2026 10:59:34 am

Stock Data

Market Cap:	$1,508,423,728
Float:	49,696,926
Insiders Ownership:	N/A
Institutions:	16
Short Percent:	N/A
Industry:	Biotechnology & Life Sciences
Sector:	Healthcare
Website:	https://www.oculis.com
Country:	CH
City: